|
CN1615837A
|
|
Emulsion containing dicaffeoyl quinic acid and its preparing method
|
|
CN1615838A
|
|
Composition containing dicaffeoyl quinic acid and its preparing method
|
|
CN1706813A
|
|
Medicine precursor containing long chain fatty acyl group substituted venlafaxine and its prepn and use
|
|
CN1449751A
|
|
Use of dicaffeoylquinic acid derivative and analogs in treating disease related to coronavirus infection
|
|
CN1502334A
|
|
Medicinal composition containing Adefovirdipivoxil
|
|
CN1483394A
|
|
Anti-perspirant deodorizing composition and preparation process thereof
|
|
CN1432654A
|
|
Nucleic acid detecting sensitivity raising method
|
|
CN1408439A
|
|
Use of CC(A+T)6 GG series sequence in tumor gene radio therapy
|
|
CN1398586A
|
|
New substituted heptoic acid derivative for treating bronchial asthma and chronic obstructive pulmonary tuberculosis
|
|
CN1393567A
|
|
Preparing process and usage of oligonucleotide gene chip for testing medicine resistance of hepatitis B virus
|
|
CN1386858A
|
|
3 novel humanized tumor cell reproduction and tumor transfer suppressor genes
|
|
CN1382686A
|
|
Process for preparing 3-aminobenzoylamine
|
|
CN1380300A
|
|
Deoxyribozymeoligonucleotide structure for inhibiting telomerase activity and its application
|
|
CN1370533A
|
|
Application of new benzothiophene compound in preventing and treating women's post-menopause syndrome and other estrogen relative diseases
|
|
CN1289922A
|
|
Biochemical process for preparing liquid-phase chromatograph
|
|
CN1279953A
|
|
Application of seeweed polyose sulphate
|
|
CN1284334A
|
|
Medicinal composition for treating AlDS
|
|
CN1331969A
|
|
Antitumor acive matter
|
|
CN1277034A
|
|
Chinese medicine preparation
|
|
CN1298701A
|
|
Compound amino acid composition
|
